These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 7372374

  • 1. Inhibition of effector cell functions in natural killer cell activity (NK) and antibody-dependent cellular cytotoxicity (ADCC) in mice by normal and cancer sera.
    Nair PN, Fernandes G, Onoe K, Day NK, Good RA.
    Int J Cancer; 1980 May 15; 25(5):667-77. PubMed ID: 7372374
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Dissociation of natural killer activity and antibody-dependent cellular cytotoxicity in spleen cells of tumor bearing mice.
    Ono M, Tanaka N, Orita K.
    Acta Med Okayama; 1983 Aug 15; 37(4):367-76. PubMed ID: 6605026
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Decreased natural cytotoxicity in mice with high incidence of mammary adenocarcinoma.
    Ames IH, Garcia AM, John PA, Litty CA, Farrell MA, Tomar RH.
    Clin Immunol Immunopathol; 1986 Feb 15; 38(2):265-73. PubMed ID: 3940744
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Characterization of the effector cells mediating an "innocent bystander" cytotoxicity reaction induced by a syngeneic mammary adenocarcinoma in mice.
    Paul RD, Padmanabhan R, Lopez DM.
    Cancer Res; 1984 Oct 15; 44(10):4480-6. PubMed ID: 6467207
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Identity of effector cells participating in the reverse antibody-dependent cell-mediated cytotoxicity.
    Saxena RK, Saxena QB, Adler WH.
    Immunology; 1982 Jun 15; 46(2):459-64. PubMed ID: 7084998
    [Abstract] [Full Text] [Related]

  • 13. Antibody-dependent natural killer cell-mediated cytotoxicity engendered by a kinase-inactive human HER2 adenovirus-based vaccination mediates resistance to breast tumors.
    Triulzi C, Vertuani S, Curcio C, Antognoli A, Seibt J, Akusjärvi G, Wei WZ, Cavallo F, Kiessling R.
    Cancer Res; 2010 Oct 01; 70(19):7431-41. PubMed ID: 20823150
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Corretation between immunosuppression to tumorigenesis. 1. Humoral immunosuppressing factor.
    Hakim AA.
    Eur J Cancer (1965); 1978 Nov 01; 14(11):1249-60. PubMed ID: 738330
    [No Abstract] [Full Text] [Related]

  • 17. Emergence of a B lymphocyte population with ADCC effector function in mammary tumor bearing mice.
    Padmanabhan RR, Paul RD, Watson GA, Lopez DM.
    J Leukoc Biol; 1988 Jun 01; 43(6):509-19. PubMed ID: 3259973
    [Abstract] [Full Text] [Related]

  • 18. Immunological responses to a murine mammary adenocarcinoma: cytolysis by armed monocyte and by antibody-dependent cellular cytotoxicity.
    Yamamura Y.
    Oncology; 1980 Jun 01; 37(1):6-11. PubMed ID: 7350556
    [Abstract] [Full Text] [Related]

  • 19. The level of MHC class I expression on murine adenocarcinoma can change the antitumor effector mechanism of immunocytokine therapy.
    Imboden M, Murphy KR, Rakhmilevich AL, Neal ZC, Xiang R, Reisfeld RA, Gillies SD, Sondel PM.
    Cancer Res; 2001 Feb 15; 61(4):1500-7. PubMed ID: 11245457
    [Abstract] [Full Text] [Related]

  • 20. Nuclear disintegration of target cells by killer B lymphocytes from tumor-bearing mice.
    Lopez DM, Blomberg BB, Padmanabhan RR, Bourguignon LY.
    FASEB J; 1989 Jan 15; 3(1):37-43. PubMed ID: 2783411
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.